V. L. Greenberg

Histone deacetylase inhibitors enhance paclitaxel-induced cell death in ovarian cancer cell lines independent of p53 status.

Nishan H Chobanian, V. L. Greenberg, J. Gass, 2004, Anticancer research.

Quantitative and qualitative differences in growth, invasion and lung colonization of an anaplastic and a papillary human thyroid cancer cell linein vitro andin vivo

V. L. Greenberg, S. Zimmer, K. Ain, 1996, Clinical & Experimental Metastasis.

Paclitaxel induces the phosphorylation of the eukaryotic translation initiation factor 4E-binding protein 1 through a Cdk1-dependent mechanism

V. L. Greenberg, S. Zimmer, 2005, Oncogene.

Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells.

V. L. Greenberg, S. Zimmer, J. Cogswell, 2001, Thyroid : official journal of the American Thyroid Association.

Butyrate alters the expression and activity of cell cycle components in anaplastic thyroid carcinoma cells.

V. L. Greenberg, S. Zimmer, J. Williams, 2001, Thyroid : official journal of the American Thyroid Association.

In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer.

V. L. Greenberg, J. van Nagell, S. Zimmer, 2007, Gynecologic oncology.

Quantitative and qualitative differences in growth, invasion and lung colonization of an anaplastic and a papillary human thyroid cancer cell line in vitro and in vivo.

V. L. Greenberg, S. Zimmer, K. Ain, 1996, Clinical & experimental metastasis.

Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.

V. L. Greenberg, C. Desimone, J. van Nagell, 2010, Gynecologic oncology.